Download Full Text (1.7 MB)

Document Type



The purpose of this research and systematic literature review is to compare the drug ketamine’s efficacy at treating post-traumatic stress disorder for veterans and active-duty military compared to approved Food and Drug Administration (FDA) options and combination medication/psychotherapy. In this review, three databases were searched including Pubmed, ClinicalKey, and PsycInfo from October 3 to January 9, 2023. Additionally, the Veterans Affairs (VA)/Department of Defense (DOD) Clinical Practice Guidelines was utilized. A variety of key and mesh terms were utilized when database searching. Chosen works for review included randomized control trials, systematic reviews, meta-analysis, and retro-perspective studies. Sources that were excluded included those published prior to the year 2010, multiple co-morbidities, non-veteran, and non-military. In total, 18 resources were selected. Most of the research presented shows evidence for the use of serotonin reuptake inhibitors (SSRIs) and cognitive behavioral therapy (CBT) as the gold standard of treatment for PTSD.


Physician Assistant Studies

Degree Name

Master of Physician Assistant Studies (MPAS)

Publication Date

Spring 2023


Medicine and Health Sciences

Ketamine for active-duty military and veterans with PTSD